Effectiveness of drug dependence treatment in HIV prevention

International Journal of Drug Policy

Volumn 16, Issue SUPPL. 1, 2005, Pages 67-75

  Farrell, Michael ^a   Gowing, Linda ^b   Marsden, John ^a   Ling, Walter ^c   Ali, Robert ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Burprenorphine; HIV; Injection drug use; Methadone; Prevention; Risk reduction; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT; BUPRENORPHINE; COCAINE; DIAMORPHINE; EFAVIRENZ; METHADONE; NALTREXONE; OPIATE; ZIDOVUDINE;

ABSTINENCE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONDITIONING; COST EFFECTIVENESS ANALYSIS; DETOXIFICATION; DRUG ABSORPTION; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG METABOLISM; DRUG URINE LEVEL; HEALTH BEHAVIOR; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW DRUG DOSE; OPIATE ADDICTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RISK REDUCTION; SEXUAL BEHAVIOR; VIRUS TRANSMISSION; WITHDRAWAL SYNDROME;

EID: 28444468787     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2005.02.008     Document Type: Article

References (57)

1. J. Ahmadi Methadone vs. buprenorphine maintenance for the treatment of heroin-dependent outpatients Journal of Substance Abuse Treatment 24 2003 217 220
2. American Psychiatric Association. (1995). Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids. American Journal of Psychiatry, 152(11 Suppl.), 1-59.
3. A. Antela, J.L. Casado, M.J. Gonzalez, P. Perez, M.J. Perez-Elias, and P. Montilla Influence of a methadone maintenance programme on the improved outcome of a cohort of injecting drug users with advanced HIV disease AIDS 11 11 1997 1405 1406
4. M. Auriacombe, M. Fatseas, J. Dubernet, J.P. Daulouede, and J. Tignol French field experience with buprenorphine American Journal on Addictions 13 Suppl. 1 2004 S17 S28
5. S.K. Avants, L.A. Warburton, K.A. Hawkins, and A. Margolin Continuation of high-risk behavior by HIV-positive drug users. Treatment implications Journal of Substance Abuse Treatment 19 1 2000 15 22
6. A. Baker, and N.K. Lee A review of psychosocial interventions for amphetamine use Drug and Alcohol Review 22 3 2003 323 335
7. P.G. Barnett, J.H. Rodgers, and D.A. Bloch A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence Addiction 96 5 2001 683 690
8. L.S. Brahen, R.K. Henderson, T. Capone, and N. Kordal Naltrexone treatment in a jail work-release program Journal of Clinical Psychiatry 45 9 Sec. 2 1984 49 52
9. D.A. Bux, R.J. Lamb, and M.Y. Iguchi Cocaine use and HIV risk behavior in methadone maintenance patients Drug and Alcohol Dependence 37 1 1995 29 35
10. L.M. Camacho, N.G. Bartholomew, G.W. Joe, M.A. Cloud, and D.D. Simpson Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance Drug and Alcohol Dependence 41 1 1996 1 7
11. K.M. Carroll Treating drug dependence: Recent advances and old truths W.R. Miller N. Heather Treating addictive behaviours 1998 Plenum Press New York 217 229
12. J.W. Cornish, D.S. Metzger, G.E. Woody, D. Wilson, A.T. McLellan, and B. Vandergrift Naltrexone pharmacotherapy for opioid dependent federal probationers Journal of Substance Abuse Treatment 14 6 1997 529 534
13. P. Crits-Christoph, L. Siqueland, J. Blaine, A. Frank, L. Luborsky, and L.S. Onken Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study Archives of General Psychiatry 56 6 1999 493 502
14. S. Darke, W. Swift, W. Hall, and M. Ross Drug use HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients Drug and Alcohol Dependence 34 1993 67 70
15. S. Darke, J. Ross, M. Teesson, R. Ali, R. Cooke, and A. Ritter Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS) Journal of Substance Abuse Treatment 28 3 2005 255 263
16. G. De Leon The therapeutic community: Theory, model, and method 2000 Springer Publishing Co. Inc. New York, NY, United States
17. D.C. Des Jarlais, S.R. Friedman, J. Woods, and J. Milliken HIV infection among intravenous drug users: Epidemiology and emerging public health perspectives J.H. Lowinson P. Ruiz R.B. Millman J.G. Langrod Substance abuse: A comprehensive textbook 1992 Williams and Wilkins Baltimore 734 743
18. R. Fiorentine After drug treatment: Are 12-step programs effective in maintaining abstinence? American Journal of Drug and Alcohol Abuse 25 1 1999 93 116
19. R. Fiorentine, and M.P. Hillhouse Drug treatment and 12-step program participation: The additive effects of integrated recovery activities Journal of Substance Abuse Treatment 18 1 2000 65 74
20. D.R. Gerstein, and H. Harwood CALDATA general report California Department of Alcohol and Drug Programs 1994
21. C. Godfrey, D. Stewart, and M. Gossop Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS) Addiction 99 6 2004 697 707
22. M. Gossop, J. Marsden, and D. Stewart NTORS at one year: Changes in substance use, health and criminal behaviour one year after intake 1998 Department of Health London
23. L.R. Gowing, R.L. Ali, and J.M. White The management of opioid withdrawal Drug and Alcohol Review 19 3 2000 309 318
24. L. Gowing, R. Cooke, A. Biven, and D. Watts Towards better practice in therapeutic communities 2002 Australasian Therapeutic Communities Association, Canberra Australia
25. L. Gowing, M. Farrell, R. Bornemann, and R. Ali Substitution treatment of injecting opioid users for prevention of HIV infection [Cochrane Review] The cochrane library (Issue 4) 2004 John Wiley and Sons Ltd. Chichester, UK
26. M. Gossop, J. Marsden, D. Stewart, C. Edwards, P. Lehmann, and A. Wilson The national treatment outcome research study in the United Kingdom: Six-month follow-up of outcomes Psychology of Addictive Behaviors 11 4 1997 324 337
27. J.D. Griffith, G.A. Rowan-Szal, R.R. Roark, and D.D. Simpson Contingency management in outpatient methadone treatment: A meta-analysis Drug and Alcohol Dependence 58 1 2000 55 66
28. W. Hall, J. Ward, and R.P. Mattick The effectiveness of methadone maintenance treatment 1: Heroin use and crime J. Ward R.P. Mattick W. Hall Methadone maintenance treatment and other opioid replacement therapies 1998 Harwood Academic Publishers Amsterdam 17 57
29. R.L. Hubbard, S.G. Craddock, P.M. Flynn, J. Anderson, and R.M. Etheridge Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS) Psychology of Addictive Behaviors 11 4 1997 261 278
30. R.E. Johnson Review of US clinical trials of buprenorphine Research and Clinical Forums 19 3 1997 17 23
31. R.E. Johnson, E.C. Strain, and L. Amass Buprenorphine: How to use it right Drug and Alcohol Dependence 70 Suppl. 2 2003 59 S77
32. J.L. Kelley, and N.M. Petry HIV risk behaviors in male substance abusers with and without antisocial personality disorder Journal of Substance Abuse Treatment 19 1 2000 59 66
33. U. Kirchmayer, M. Davoli, and A. Verster Naltrexone maintenance treatment for opioid dependence [Cochrane Review] The cochrane library (Issue 3) 2003 John Wiley and Sons Ltd. Chichester, UK
34. M.J. Kreek Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine Annals of the New York Academy of Sciences 909 2000 186 216
35. R.P. Mattick, J. Ward, and W. Hall The role of counselling and psychological therapy J. Ward R.P. Mattick W. Hall Methadone maintenance treatment and other opioid replacement therapies 1998 Harwood Academic Publishers Amsterdam 265 304
36. R.P. Mattick, C. Breen, J. Kimber, and M. Davoli Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence [Cochrane Review] The cochrane library (Issue 4) 2002 John Wiley and Sons Ltd. Chichester, UK
37. R.P. Mattick, J. Kimber, C. Breen, and M. Davoli Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence [Cochrane Review] The cochrane library (Issue 3) 2003 John Wiley and Sons Ltd. Chichester, UK
38. E.F. McCance-Katz, P. Jatlow, P. Rainey, and G. Friedland Methadone effects on zidovudine (AZT) disposition (ACTG 262) Journal Acquired Immune Deficiency Syndrome Human Retrovirology 18 1998 435 443
39. E.F. McCance-Katz, P.M. Rainey, G. Friedland, T.R. Kosten, and P. Jatlow Effect of opioid dependence pharmacotherapies on zidovudine disposition American Journal Addictions 10 2001 296 307
40. E.F. McCance-Katz, M.N. Gourevitch, J. Arnsten, J. Sarlo, P. Rainey, and P. Jatlow Modified Directly Observed Therapy (MDOT) for injection drug users with HIV disease American Journal Addictions 11 2002 271 278
41. A.T. McLellan, I.O. Arndt, D.S. Metzger, G.E. Woody, and C.P. O'Brien The effects of psychosocial services in substance abuse treatment Journal of the American Medical Association 269 15 1993 1953 1959
42. P.G. O'Connor, P.A. Selwyn, and R.S. Schottenfeld Medical care for injection-drug users with human immunodeficiency virus infection New England Journal of Medicine 331 7 1994 450 459
43. J.E. Powell, and D. Taylor Evaluation of a residential detoxification and motivational program: The Wollongong Crisis Centre Report of a project funded by the Australian Research Into Drug Abuse Program of the National Campaign Against Drug Abuse 1989 Commonwealth of Australia Canberra
44. J. Shearer, and L.R. Gowing Pharmacotherapies for problematic psychostimulant use: A review of current research Drug and Alcohol Review 23 2 2004 203 211
45. J.L. Sorensen, and A.L. Copeland Drug abuse treatment as an HIV prevention strategy: A review Drug and Alcohol Dependence 59 1 2000 17 31
46. G.V. Stimson AIDS and injecting drug use in the United Kingdom 1987-1993 the policy response and the prevention of the epidemic Social Science and Medicine 41 5 1995 699 716
47. R.W. Swindle, K.A. Peterson, M.J. Paradise, and R.H. Moos Measuring substance abuse program treatment orientations: The Drug and Alcohol Program Treatment Inventory Journal of Substance Abuse 7 1995 61 78
48. T.K. Tucker, and A.J. Ritter Naltrexone in the treatment of heroin dependence: A literature review Drug and Alcohol Review 19 1 2000 73 82
49. UNODC. (2003). Investing in drug abuse treatment. A discussion paper for policy makers. United Nations, New York, United States.
50. Joint WHO/UNAIDS/UNODC. (2003). Position paper on substitution treatment. Geneva, Switzerland.
51. J. Ward, R.P. Mattick, and W. Hall The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome J. Ward R.P. Mattick W. Hall Methadone maintenance treatment and other opioid replacement therapies 1998 Harwood Academic Publishers Amsterdam 205 238
52. A.M. Washton, M.S. Gold, and A.C. Pottash Naltrexone in addicted physicians and business executives Journal of Clinical Psychiatry 45 9 1984 39 41
53. R. Weber, B. Ledergerber, M. Opravil, W. Siegenthaler, and R. Luthy Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone British Medical Journal 301 6765 1990 1362 1365
54. R.D. Weiss, M.L. Griffin, L.M. Najavits, C. Hufford, J. Kogan, and H.J. Thompson Self-help activities in cocaine dependent patients entering treatment: Results from NIDA collaborative cocaine treatment study Drug and Alcohol Dependence 43 1-2 1996 79 86
55. S.L. West, K.K. O'Neal, and C.W. Graham A meta-analysis comparing the effectiveness of buprenorphine and methadone Journal of Substance Abuse 12 4 2000 405 414
56. World Health Organization, United Nations Office on Drugs and Crime, & Joint United Nations Programme on HIV/AIDS. (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: Position paper. Geneva, Switzerland: World Health Organization.
57. D.A. Zador, M. Adams, and K.H. Curry Clinical experience with naltrexone maintenance in a hospital drug and alcohol outpatient setting Medical Journal of Australia 171 9 1999 501